Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 7;31(11):1630-1649.e8.
doi: 10.1016/j.stem.2024.09.010. Epub 2024 Oct 15.

A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice

Affiliations

A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice

Taylor S Mills et al. Cell Stem Cell. .

Abstract

Here, we investigate the contribution of long-term hematopoietic stem cells (HSCsLT) to trained immunity (TI) in the setting of chronic autoimmune disease. Using a mouse model of systemic lupus erythematosus (SLE), we show that bone marrow-derived macrophages (BMDMs) from autoimmune mice exhibit hallmark features of TI, including increased Mycobacterium avium killing and inflammatory cytokine production, which are mechanistically linked to increased glycolytic metabolism. We show that HSCs from autoimmune mice constitute a transplantable, long-term reservoir for macrophages that exhibit the functional properties of TI. However, these BMDMs exhibit reduced glycolytic activity and chromatin accessibility at metabolic genes while retaining elevated expression of TI-associated transcriptional regulators. Hence, HSC exposed to autoimmune inflammation can give rise to macrophages in which the functional and metabolic properties of TI are decoupled. Our data support a model in which TI is characterized by a spectrum of molecular and metabolic states driving augmented immune function.

Keywords: autoimmune disease; bone marrow-derived macrophage; hematopoietic stem cell; inflammation; metabolism; trained immunity.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Wang L, Wang F-S, and Gershwin ME (2015). Human autoimmune diseases: a comprehensive update. J Intern Med 278, 369–395. 10.1111/joim.12395. - DOI - PubMed
    1. Davidson A, and Diamond B. (2001). Autoimmune diseases. N Engl J Med 345, 340–350. 10.1056/NEJM200108023450506. - DOI - PubMed
    1. Theofilopoulos AN, Kono DH, and Baccala R. (2017). The multiple pathways to autoimmunity. Nat Immunol 18, 716–724. 10.1038/ni.3731. - DOI - PMC - PubMed
    1. Dinse GE, Parks CG, Weinberg CR, Co CA, Wilkerson J, Zeldin DC, Chan EKL, and Miller FW (2020). Increasing Prevalence of Antinuclear Antibodies in the United States. Arthritis Rheumatol 72, 1026–1035. 10.1002/art.41214. - DOI - PMC - PubMed
    1. Lerner A, Jeremias P, and Matthias T. (2016). The World Incidence and Prevalence of Autoimmune Diseases is Increasing. International Journal of Celiac Disease 3, 151–155. 10.12691/ijcd-3-4-8. - DOI